KU-60019 B018304 Smiles: CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C21

Smiles: CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C21

is the product of hydrolysis by acids

Drug Improves Survival in Refractory Colorectal Cancer

CAS Number: 13189-98-5

The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3

KU-60019 B018304 Smiles: CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H]1[C@H](O)CC2=CC=CC=C21KU 60019 is a potent and selective ATM inhibitor. KU 60019 is 10 fold more effective than KU 55933 at blocking radiation induced phosphorylation of key ATM targets in human glioma cells. As expected, KU 60019 is a highly effective radiosensitizer of human glioma cells. KU 60019 inhibits the DNA damage response, reduces AKT phosphorylation and prosurvival signaling, inhibits migration and invasion, and effectively radiosensitizes human glioma cells